ANI Pharma (ANIP) Tops Q1 EPS by 1c

ANI Pharma (NASDAQ: ANIP) reported Q1 EPS of $0.57, $0.01 better than the analyst estimate of $0.56. Revenue for the quarter came in at $18.8 million versus the consensus estimate of $19.9 million.

For earnings history and earnings-related data on ANI Pharma (ANIP) click here.

You May Also Be Interested In

• ATN International (ATNI) Misses Q1 EPS by 46c ; Offers Guidance
• Alamos Gold (AGI) Misses Q1 EPS by 1c
• First Bancorp. (FBNC) Misses Q1 EPS by 2c